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ABSTRACT 
 
Periodontal Wound Healing/Regeneration Following 
Application of Recombinant Human Growth/Differentiation 
Factor-5 in a ß-Tricalcium Phosphate or an Absorbable 
Collagen Sponge Carrier into  
One-Wall Intrabony Defects in Dogs 
 
 
Requirements for biomaterials considered as carriers for biologic agents for 
tissue engineering in periodontal sites includes applicability, biocompatibility, 
structural integrity, adequate release kinetics for the biologic agent and bioresorption 
profile. The objective of this study was to evaluate periodontal wound healing/ 
regeneration following application of recombinant human growth/differentiation 
factor-5 in a synthetic, particulate, highly porous, bioresorbable, osteoconductive ß-
tricalcium phosphate scaffold (rhGDF-5/ß-TCP) compared to periodontal wound 
healing/regeneration following application of rhGDF-5 in an absorbable collagen 
sponge (rhGDF-5/ACS) matrix in an one-wall intrabony defect model in the Beagle 
dog.  
 
Unilateral, critical-size (5-mm), one-wall, intrabony periodontal defects were 
surgically created in the mandibular premolar region in ten Beagle dogs. Unilateral 
 iv
defects in five animals received rhGDF-5/ß-TCP while the remaining five animals 
similarly received rhGDF-5/ACS. The animals were euthanized for hisopathologic 
and histiometric analysis following an 8-week healing interval. 
rhGDF-5/ACS and rhGDF-5/ß-TCP groups all showed enhanced bone 
formation. G-TCP group showed better bone formation in bone height and bone 
volume than G-ACS groups. 
 
rhGDF-5/ß-TCP showed significant enhanced bone formation. rhGDF-5/ß-TCP 
seems to releases rhGDF-5 over a long period of time as well as serving as a space 
maintainer. These results suggest that β-TCP appears as suitable carrier for rhGDF-5 
for periodontal inlay indications.  
 
 
 
 
 
 
 
Key words : rhGDF-5, tissue engineering, periodontal regeneration, β-TCP, 
absorbable collagen sponge, dog 
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I. INTRODUCTION 
 
For tissue engineering, we should consider three determinants, cells, scaffolds, 
and signaling molecules (Babensee et al. 2000; Bartold et al. 2006). Blood supplies 
could be an additional factor for tissue engineering. Since cells and blood supplies are 
not controllable factors, scaffolds and signaling molecules would be the true 
determinants for the investigators and clinicians.  
 
The bone morphogenetic protein (BMP) acting as a signaling molecule, is now 
regarded as a good additive for periodontal regeneration or bone regeneration (Wang 
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et al. 1990; Sampath et al. 1992; Ripamonti et al. 1994; Giannobile et al. 2003; Taba 
et al. 2005). Studies have shown that BMP-2, -4, -5, -6 and -7 have osteoinductive 
properties (Yamaguchi et al. 1991; Chang et al. 1994; King et al. 1997). However, 
these BMPs showed complications like root resorption or ankylosis (Saito et al. 2003; 
Wikesjo et al. 2004), while GDF-5, -6 and -7 (BMP-14, -13, -12) are known as 
cartilage and bone inducing proteins without root resoprtion and ankylosis. 
Recombinant human growth/differentiation factor-5 (rhGDF-5), a member of the 
transforming growth factor-β superfamily was reported as a suitable factor for 
enhancing healing in bone defect and ectopic bone formation (Spiro et al. 2000; 
Yoshimoto et al. 2006).  
 
The absorbable collagen is regarded as a gold standard of a BMP carrier 
(McPherson 1992; Uludag et al. 2001; Kleinman et al. 2003). However it has a 
significant limitation that it easily collapses and is absorbed too early to release 
enough signaling molecules (Bartold et al. 2000; King et al. 2002; Bartold et al. 2006). 
New forms of carriers are required to overcome these two aspects. Currently many 
resorbable scaffolds chemically synthesized are being introduced. Polyglycolic acid 
(PLA), polylactic acid (PGA), poly(lactic-co-glycolic acid) (PLGA), Hydroxyapatite, 
and β-Tricalcium phosphate (β-TCP) are those (Giannobile 1996; Babensee et al. 
2000; Taba et al. 2005; Bartold et al. 2006). Growth factor requires appropriate 
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scaffolds to apply to defect sites. 
β-TCP is a bioresorbable and biocompatible material (Urist et al. 1984; Urist et 
al. 1987; Jung et al. 2006; Poehling et al. 2006), and it is expected to maintain the 
space long enough for the bone regeneration. Growth and differentiation factor-5 is 
also named cartilage-derived morphogenic protein-1 (CDMP-1) and its properties of 
chondrogenesis, osteogenesis and angiogenesis are being reported (Yamashita et al. 
1997; Spiro et al. 2000; Kuniyasu et al. 2003; Poehling et al. 2006; Yoshimoto et al. 
2006; Zeng et al. 2006). In the present study, the materials used are Beta-Tricalcium 
phosphate (β-TCP) coated with recombinant human growth/differentiation facor-5 
(rhGDF-5) (Poehling et al. 2006). The aim of this study was to estimate the effect of 
rhGDF-5 with β-TCP carrier (G-TCP) compared to ACS carrier (G-ACS) in the 
beagle dog 1-wall defect model. 
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II. MATERIALS AND METHODS 
 
A. Animals 
 
Ten male Beagle dogs, approximately 15 months old, weight 10-15 kg, bred 
exclusively for biomedical research purposes, were used. The animals exhibited an 
intact dentition with a healthy periodontium. Animal selection and management, 
surgical protocol, and preparation followed routines approved by the Institutional 
Animal Care and Use Committee, Yonsei Medical Center, Seoul, Korea. The animals 
had ad libitum access to water and a pelleted laboratory diet with the exception of one 
week immediately postsurgery when they were fed a canned soft dog food diet 
(Prescription Diet Canine i/d, Hill’s Pet Nutrition, Inc., Topeka, Kansas, USA). 
 
B. Materials 
 
G-TCP is composed of β-TCP carrier that is coated with homogeneously with 
rhGDF-5. The β-TCP particle size ranges between 500 and 1000 µm featuring 
interconnecting porosity. The rhGDF-5 dose was 500 µg/gram β-TCP.  
 
G-ACS is the absorbable collagen sponge§, which is soak-laoded with rhGDF-5. 
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The collagen sponges were natural-born and bio-absorbable. The applied dose is 
estimated approximately same as G-TCP, 20 µg rhGDF-5 per each defect.  
 
C. Surgical Procedures 
 
All surgical procedures including extraction and experiment were performed 
under general anesthesia. Induction by intravenous injection of atropin∥ and 
intramuscular injection of a combination of xylazine¶ and ketamin# were performed 
and the general anesthesia was maintained with inhalation anesthesia**. 
 
After the extraction of first premolar and third premolar, 8 weeks were given for 
complete socket healing. After the infiltration anesthesia, full thickness 
mucoperiosteal flap was elevated to make 1-wall defect at the pre-extraction site. The 
defects surgically created as “box-type” (4 mm width, 5 mm depth), one-wall, 
intrabony defects were made distal to the first premolar and mesial to the third 
premolar(Kim, H. Y. et al. 2002; Kim, C. S. et al. 2005). Defects in the test group 
were filled with G-TCP. In the other five dogs, G-ACS was applied. 
 
Next, the mucoperiosteal flaps were advanced, adapted, and sutured with 
resorbable suture materials††.  
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Post-surgical management included intramuscular administration of antibiotics‡‡ 
for 3 days and daily topical dressing of 0.2% chlorhexidine solution§§ for infection 
control for 7 days. 
The extraction sites were allowed to heal for 2 months. The remaining dentition 
received oral prophylaxis in conjunction with the extraction procedures. The animals 
were euthanized 8 weeks following the first surgical procedure and block sections 
including the surgical sites were removed for the histologic analysis. 
 
D. Clinical and Radiographic Records 
 
Clinical photos and radiographs were taken at the time of the extraction, the 
surgery and the necropsy. At each time, before and after photos and radiographs were 
recorded.  
 
E. Histologic & Histometric Analysis 
 
The animals were sacrificed using an overdose of pentobarbital (90 -120 mg/kg; 
IV). Block sections including defect sites and tooth, surrounding alveolar bone and 
soft tissues were collected. The block specimens were fixed in 10% buffered formalin 
for 10 days, decalcified in 5% nitric acid for 7 days, trimmed, dehydrated and 
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embedded in paraffin. Serial sections, 4µm thick, were cut in a mesial-distal direction 
at 80µm intervals. The sections were stained using hematoxylin and eosin. 
 
The three most central sections of each defect site were observed using 
incandescent and polarized light microscopy∥∥. Histometric analysis was performed 
using image analysis software¶¶. The following parameters were recorded (Figure 2). 
o Defect height: distance from the apical extension of the root surface notch to the 
cemento-enamel junction (CEJ); 
o Epithelial attachment: distance from the CEJ to the apical extension of an 
epithelial attachment on the root surface. This parameter included any gingival 
recession. 
o Cementum regeneration: distance from the apical extension of the root surface 
notch to the coronal extension of newly formed cementum or a cementum-like 
substance on the root surface. 
o Bone regeneration (height): distance from the apical extension of the root surface 
notch to the coronal extension of newly formed bone along the root surface; 
o Bone regeneration (area): new alveolar bone within the standardized template 
that served as a proxy for the defect site. The template was aligned parallel to the root 
surface interfacing the apical extension of defect at the root surface notch. 
o Root resorption 
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o Ankylosis  
 
F. Statistical Analysis 
The experimental groups were G-TCP groups were compared to the G-ACS groups 
using student t-test (p < 0.05) with Statistics software##. 
 
 
 
 
 
 
 
 
 
§ Colla-tape®, Zimmer Dental, Carlsbad, CA, USA 
∥0.04 mg/kg; Kwangmyung Pharmaceutical Ind. Co. Ltd., Seoul, Korea 
¶ Rompun, Bayer Korea Co., Seoul, Korea 
# Ketara, Yuhan Co., Seoul, Korea 
** Gerolan, Choongwae Pharmaceutical Co., Seoul, Korea 
†† Vicryl 5.0 Polyglactin 910, Ethicon, Johnson & Johnson, New Jersey, USA 
‡‡ Cefazoline Sodium 20mg/kg; Yuhan Corporation, Seoul, Korea 
§§ Hexamedin®, Bukwang Pharmaceutical Co., Seoul, Korea 
∥∥Olympus Multi-view microscope BH2, Tokyo, Japan 
¶¶ Image-Pro Plus, Media Cybernetic, Silver Springs, MD, USA 
## Microsoft Office Excel 2003, Microsoft Co., Redmond, WA, USA 
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III. RESULTS 
 
A. Clinical & Radiographic Observations 
 
No sign of infection or other clinical complications were observed during the 
eight-week healing interval. Figure 1 shows the clinical observations at surgery and 
necropsy for each group. Figure 3 shows representative radiographs of the each group 
at the time of surgery and necropsy suggesting greater bone formation at defect sites 
implanted with G-TCP compared to G-ACS. 
 
B. Histologic & Histometric Analysis 
 
Results from the histometric analysis are shown in Table 1. The defect height 
averaged (± SD) 5.01 ± 0.51 mm and 4.58 ± 0.54 mm respectively for the defects 
receiving the G-ACS, and G-TCP with no significant differences between the 
treatments (p > 0.05). The junctional epithelium was 1.55 ± 1.18 mm and 0.65 ± 0.33 
mm for the defects receiving the G-ACS and G-TCP respectively without significant 
differences. Amount of the cementum regeneration averaged 3.03 ± 1.18 and 3.83 ± 
0.73mm respectively without significant differences. 
Dense fibers showing periodontal regeneration were embedded into the newly 
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formed bone and new cellular cementum obliquely or perpendicularly (Figure 5). 
 
Mean values of bone regeneration show 2.22 ± 0.82 mm and 3.26 ± 0.30 mm for 
G-ACS and G-TCP respectively with significant differences between two groups (p < 
0.05). Significant differences between 2 groups were shown in bone regeneration 
volumes (p < 0.05). G-TCP showed greater regenerated bone height and greater 
regenerated bone volume than G-ACS (p < 0.05). The woven nature of the new bone 
was shown and it appeared hypercellularity and higher density in both G-TCP and G-
ACS groups (Figure 6). 
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IV. DISCUSSION 
 
Periodontal defects can be restored in many ways. Different methods such as 
resective therapies, bone grafting, and guided tissue/bone regeneration were tried 
(Giannobile 1996; Taba et al. 2005; Bartold et al. 2006). Recently, a combination of 
several techniques was introduced as the tissue engineering technique improves 
(Bartold et al. 2000; Bartold et al. 2006). Bone morphogenetic proteins or growth 
factors have been studied in this aspect. RhGDF-5 is one of the bone morphogenetic 
protein family of the TGF-β superfamily and they were reported as having abilities of 
chondrogenesis, osteogenesis and angiogenesis (Francis-West et al. 1999). RhGDF-5 
displays strong osteoinductive ability with limited risk of excessive bone formation 
(Kuniyasu et al. 2003). In the present study, G-ACS group and G-TCP group showed 
44.31% and 71.18% of new bone formation respectively and G-TCP had significantly 
more bone formation than G-ACS. This result supports that the rhGDF-5 has the 
ability of osteogenesis, assuring previous literatures (Yamashita et al. 1997; Spiro et 
al. 2000; Kuniyasu et al. 2003; Poehling et al. 2006; Yoshimoto et al. 2006; Zeng et al. 
2006). Ankylosis or root resorption was not observed in the present study.  
 
As well as bone formation, periodontal regeneration is one of the goals for tissue 
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engineering. For measuring the periodontal regeneration, cementum regeneration was 
measured and periodontal ligament was observed. In the cementum regeneration, G-
ACS and G-TCP group showed 60.47% and 83.62% of new cementum formation 
with no significant difference between two groups. Compared to 30 to 35% of 
cementum regenetation in 1-wall defect without treatment (Kim, H. Y. et al. 2002; 
Kim, C. S. et al. 2004; Kim, C. S. et al. 2005), it is assumed that G-ACS and G-TCP 
both have the enhanced cementum regeneration, which implicates the periodontal 
regeneration. In histologic observation, dense and well organized form of periodontal 
ligaments was shown. RhGDF-5 seems to be very effective in periodontal 
regeneration with these two carriers. 
 
BMPs and proteins are applied to periodontal or bony defects with or without 
delivery devices. Not only fillers but also many other materials are developed as 
delivery devices, so called, carriers. In this study, the carrier was brought into focus. 
The delivery devices should have several characteristics. It should be: (1) porous, to 
allow cell infiltration; (2) biocompatible, to minimize inflammatory reactions; and (3) 
biodegradable, so as not to interfere with the long-term properties of the repaired 
tissue (Seeherman 2001). The absorbable collagen sponge has been a gold standard as 
a carrier (McPherson 1992). It has been utilized as a biomaterial, which allows 
fibroblast invasion, neovascularization and epidermal regeneration. And its releasing 
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time could be also somewhat controlled. But it has limitations on several aspects. The 
absorbable collagen sponge is easily collapsed. That is, the space for periodontal or 
bone regeneration is not maintained for an appropriate time. The other possibility is 
the short releasing time. Although some articles say the releasing time could be 
controlled, the time is short and it cannot be said that it release the BMPs or growth 
factors proportionally (McPherson 1992; Uludag et al. 2001; Kleinman et al. 2003). 
So many other biomaterials were developed and studied. β-TCP is the one of them. It 
is slowly absorbed and its framework makes the space maintained for enough time. 
Most of all, many methods to make proteins and growth factors released from β-TCP 
slowly were developed (Fournier et al. 1996; Whang et al. 1998; Liu et al. 2006; Park 
et al. 2006). RhGDF-5 is released in a controlled fashion over a period of 7 days. The 
sustained release characteristics of rhGDF-5 from its β-TCP carrier may contribute to 
the effectiveness of G-TCP (Poehling et al. 2006). In the present study, by comparing 
the absorbable collagen sponge and the β-TCP as a carrier, it showed significant 
differences in bone regeneration and bone area. Mean values of bone regeneration 
showed 2.22 ± 0.82, 3.26 ± 0.30 mm G-ACS, G-TCP respectively with significant 
differences between two groups (p<0.05). Significant differences in bone regeneration 
volumes (p<0.05) between 2 groups were also shown. Percentages of bone formation 
in G-TCP were 71.18%, which was superior to that of G-ACS, 44.31%. While in both 
two groups, hypercellularity and high density of new bone were observed in the 
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histologic observation, the reason for this result seems to be due to two properties 
mentioned. 
RhGDF-5/β-TCP seems to release rhGDF-5 over a long period of time as well as 
serving as a space maintainer. A framework for bone ingrowth aids in preventing the 
collapse of the soft tissues and promotes stabilization of the blood clot. These results 
suggest that β-TCP appears as a suitable carrier of rhGDF-5 for periodontal inlay 
indications.  
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V. CONCLUSION 
 
In conclusion, G-TCP release the rhGDF-5 over a long period of time as well as 
it serves as the space maintaining. But, in this study it is not certain of proportional 
releasing for a long period of time. So, further studies may be needed. Nevertheless, 
these results showed that β-TCP can be a good candidate of the rhGDF-5 carrier.  
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TABLE 
 
 
Table 1. Histomorphometric analysis (group means ± SD in mm/mm2).  
 
 rhGDF-5/ß-TCP rhGDF-5/ACS p-value 
Defect height 4.58 ± 0.54 5.01 ± 0.51 ns 
Epithelial attachment 0.65 ± 0.33 1.55 ± 1.18 ns 
Connective tissue 0.10 ± 0.10 0.43 ± 0.85 ns 
Cementum regeneration 3.83 ± 0.73 3.03 ± 1.18 ns 
Bone regeneration (height) 3.26 ± 0.30 2.22 ± 0.82 < 0.05 
Bone regeneration (area) 10.45 ± 2.26 5.48 ± 1.40 < 0.05 
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FIGURE LEGENDS 
 
Figure 1. Surgically created, critical-size, one-wall, intrabony periodontal defect at 
the distal aspect of the mandibular 2nd and mesial aspect of the mandibular 4th 
premolar teeth (left). Application of rhGDF-5/ß-TCP (left center top) or rhGDF-
5/ACS (left center bottom). Mucoperiosteal flaps adapted and sutured for primary 
intention healing (right center). Healing at week 8 (right). 
 
Figure 2. Landmarks/parameters used in the histometric analysis. The green template 
served as a proxy for the defect site for estimation of the bone regeneration area. 
 
Figure 3. Representative radiographs showing defect sites following implantation of 
rhGDF-5/β-TCP (top left) and rhGDF-5/ACS (top right) immediately postsurgery and 
at 8 weeks (bottom left and right, respectively). 
 
Figure 4. Photomicrographs from defect sites receiving rhGDF-5/β-TCP (left) and 
rhGDF-5/ACS (right) at 8 weeks. Greater bone formation can be observed at 
implanted with rhGDF-5/β-TCP compared to rhGDF-5/ACS. Aa/Ba show the apical 
extent of a junctional epithelium, Ab/Bb the coronal extension of newly formed 
alveolar bone, and Ac/Bc the apical extension (notch) of the defect sites. A few 
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residual ß-TCP particles surrounded by new bone formation can be observed (A and 
Ac). (hematoxylin/eosin, original magnification X10 & X40). 
 
Figure 5. Photomicrographs from defect sites receiving rhGDF-5/β-TCP (left) and 
rhGDF-5/ACS (right) at 8 weeks. Oblique or perpendicular oriented PDL fibers are 
inserted into newly formed bone and cementum. The PDL appears denser and well-
organized at the site receiving rhGDF-5/β-TCP (hematoxylin/eosin, original 
magnification X200). 
 
Figure 6. Photomicrographs from defect sites receiving rhGDF-5/β-TCP (left) and 
rhGDF-5/ACS (right) at 8 weeks characterized by dense, hypercellular, woven bone 
(hematoxylin/eosin, original magnification X100). 
 
Figure 7. Main results from the histometric analysis (* p < 0.05). 
 
 
 
 
 
 
 
 
 
 27
FIGURES 
 
 
 
 
Figure 1. Clinical photographs 
 
 
 
 
Figure 2. Landmarks/parameters used in the histometric analysis 
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Figure 3. Radiographs of sites 
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Figure 4. Microphotographs of defect sites(x40, x10) 
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Figure 5. Microphotographs of Periodontal ligaments (x200) 
 
 
 
 
    
 
Figure 6. Microphotographs of new bones (x100) 
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Figure 7. Histometric analysis 
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국문요약 
 
 
성견 일벽성 골내낭에서 
rh-Growth/Differentiation Factor-5의 운반체로 
ß-Tricalcium Phosphate와 Absorbable Collagen Sponge 
적용에 따른 치주조직 재생 
 
 
< 지도 교수  김 종 관 > 
연세대학교 대학원 치의학과 
김   영   택 
 
조직공학 측면에서 치주조직 재생을 위한 세가지 요소(cells, 
scaffolds, signaling molecules) 중 Scaffold로 쓰이는 재료는 조작이 
용이해야 하며, 생체적합성이 있어야 하고, 구조적인 안정성을 가져야 
한다. 또한, signaling molecule을 운반하는데 있어서 적절한 속도로 분비 
해야 하며, 그 자신 또한 염증반응없이 흡수되어야 한다. 이 실험의 
목적은 recombinant human growth/differentiation factor-5(rhGDF-5) 
를 적용함에 있어서 골형성유도 단백질을 운반하는 ‘gold standard’로 
여겨지는 absorbable collagen sponge(ACS)와, 합성물질이며 생체적 
합성이 있으며 구조적인 안정성을 갖는 beta-tricalcium phosphate(ß-
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TCP)를 비글견의 일벽성 골내낭에 적용하여 치주조직 치유와 재생의 
정도를 비교하고자 하는 것이다. 
 
10마리의 비글견에서 제3소구치를 모두 발치한 뒤, 8주간의 치유기간 
이 지나고, 제2소구치 원심면과 제4소구치 근심면에 5mm 깊이, 넓이의 
일벽성 골내낭을 형성한다. 5마리는 rhGDF-5/ß-TCP를 적용하고, 나머 
지 5마리는 rhGDF-5/ACS를 적용한다. 8주간의 치유기간이 지난 뒤, 조 
직학적인 분석과 조직계측적인 분석을 위해서 희생하였다. 
 
조직학적인 분석 결과, rhGDF-5/ß-TCP와 rhGDF-5/ACS, 두군 
모두에서 주목할 만한 골 및 백악질의 형성을 보였다. 하지만, 조직계측 
학적 분석 결과, rhGDF-5/ß-TCP군에서는 골형성 높이와 골형성 넓이 
모두에서 rhGDF-5/ACS군에 비해 유의성있는 증가를 보였다. 
 
rhGDF-5/ß-TCP군이 보인 유의성있는 골형성은 ACS에 비하여 ß-
TCP가 공간을 유지하는 역할을 할뿐만 아니라, rhGDF-5를 오랜 기간 
방출하는 역할을 하기 때문인 것으로 보인다.  
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이러한 결과는 ß-TCP가 치주 결손부위의 재생에 있어서 ACS를 
대체하여, rhGDF-5를 위한 적절한 운반체로써 쓰일 수 있음을 보여준다. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
핵심되는 말 : rhGDF-5, 조직공학, 치주재생, ß-TCP, 흡수성 콜라겐 
